தலைமை சைகடெலிக் அதிகாரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தலைமை சைகடெலிக் அதிகாரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தலைமை சைகடெலிக் அதிகாரி Today - Breaking & Trending Today

The New Drug That Could Be Bigger Than Cannabis


First, through its
HAVN Labs division, the company is devoted to providing standardized psychedelic compound formulations for academic researchers and formulators.
And second, through its
HAVN Retail division, the company is developing and bringing to market custom formulations both directly to the consumer as well as with contract manufacturing (white labeling.)
Let’s take a brief look at each of the two divisions that make up this unique, high-upside opportunity in the psychedelic space.
HAVN Life Sciences Appears Positioned to Become a Supplier of Natural Psychedelics
If you’ve devoted any time to researching or investing in the psychedelic space, you’ve likely seen that most of the companies in the industry are hoping to show that the products they’re developing offer the best potential solutions or treatments to many of the most important mental health issues. ....

Chuck Smith , Vic Neufeld , Tim Moore , Gary Leong , Ivan Casselman , Manufacturing Ltd , Regulatory Affairs , World Health Organization , Natural Health Products , Product Development , Life Sciences , Health Canada , Natural Health Product , Global Revenue , Sciences Appears Positioned , Licensed Dealer , Offers Custom Formulations , Massive Consumer Wellness , Management Team Has , Both Science , Chief Executive Officer Tim Moore , Green Growth Brands , Green Growth , Clorox Canada , Chief Scientific Officer Gary Leong , Chief Scientific Officer ,

Hot Penny Stocks Mesmerizing Traders As Psychedelic Stocks Bloom


Aikido Pharma Inc. (NASDAQ: AIKI)Penny Stocks To Watch #1: Havn Life Sciences (OTC: HAVLF) (CSE: HAVN)
Many of these psychedelic-focused companies are working on R&D., But few of them have notable names that helped carve out prior “fringe industries” like cannabis. In Havn’s case, the former CEO of Aphria (NASDAQ: APHA), Vic Neufeld, sits as the Executive Chairman. Other Aphria alumni like Gary Long, its Chief Scientific Officer, was Aphria’s former CSO. Other C-level members like Tim Moore and Eli Dusenbury were also part of the early cannabis boom related to public markets. Now, they’ve all taken positions at Havn. ....

Vic Neufeld , Tim Moore , Anthony Hayes , Ivan Casselman , Eli Dusenbury , Us Department Of Health , Human Services , Havn Life Sciences , Aikido Pharma Inc , Health Canada , Mount Sinai Center , Aptargroup Inc , Trauma Research , Penny Stocks To Buy Right , Stocks For Your , Compass Pathways , Life Sciences , Penny Stocks To Watch , Gary Long , Chief Scientific Officer , Havn Labs , Through Havn Labs , Havn Retail , Hypha Wellness Jamaica , Chief Psychedelic Officer , Horizons Psychedelic Stock Index ,